• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABYRX, INC MONTAGE SETTABLE RESORBABLE HEMOSTATIC BONE PUTTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABYRX, INC MONTAGE SETTABLE RESORBABLE HEMOSTATIC BONE PUTTY Back to Search Results
Catalog Number OS-MON-1001
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Unspecified Infection (1930)
Event Date 06/04/2022
Event Type  Injury  
Manufacturer Narrative
Abyrx has received preliminary information concerning possible adverse tissue response from a physician.Initial dos (b)(6) 2022 for mtp fusion utilizing montage in conjunction with two types of third-party amniotic tissue products and two types of third-party collagen-based products.It is unclear if the products were used in accordance with the instructions for use.Abyrx performed a review of device history records for this lot, and no irregularities or nonconformities were noted, including all aspects of sterilization.No additional complaints have been received for this lot.Abyrx will revise the complaint file if any additional information is received.
 
Event Description
Abyrx has received preliminary information concerning possible adverse event from sales agent.Additional information concerning the event is being collected.
 
Event Description
Abyrx has received preliminary information concerning possible adverse event from sales agent.Additional information concerning the event is being collected.
 
Manufacturer Narrative
Abyrx has received preliminary information concerning possible adverse tissue response from a physician.Initial dos 2022/01/12 for mtp fusion utilizing montage in conjunction with two types of third-party amniotic tissue products and two types of third-party collagen-based products.It is unclear if the products were used in accordance with the instructions for use.Abyrx performed a review of device history records for this lot, and no irregularities or nonconformities were noted, including all aspects of sterilization.No additional complaints have been received for this lot.Abyrx will revise the complaint file if any additional information is received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MONTAGE SETTABLE RESORBABLE HEMOSTATIC BONE PUTTY
Type of Device
RESORBABLE HEMOSTATIC BONE PUTTY
Manufacturer (Section D)
ABYRX, INC
1 bridge st
suite 121
irvington NY 10533
Manufacturer (Section G)
ABYRX, INC
1 bridge st
suite 121
irvington NY 10533
Manufacturer Contact
alyssa mcdermott
1 bridge st
suite 121
irvington, NY 10533
MDR Report Key15596286
MDR Text Key301657106
Report Number3005972619-2022-00003
Device Sequence Number1
Product Code MTJ
UDI-Device Identifier00850391007122
UDI-Public0100850391007122172311301010789
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K152005
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/30/2023
Device Catalogue NumberOS-MON-1001
Device Lot Number10789
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/19/2022
Initial Date FDA Received10/13/2022
Supplement Dates Manufacturer Received05/19/2022
Supplement Dates FDA Received03/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
AMNIOTIC MEMBRANE; AMNIOTIC MEMBRANE; COLLAGEN; COLLAGEN
Patient Outcome(s) Other;
Patient Age55 YR
Patient SexPrefer Not To Disclose
-
-